A novel acquired autoimmune-associated LQTS has been recently reported in adult patients carrying anti-Ro antibodies (anti-Ro Abs), 7-10 which result from an autoimmune response against the intracellular ribonucleoprotein, SSA/Ro antigen (Ro). The detection of circulating anti-Ro Abs is relatively Background-Emerging clinical evidence demonstrates high prevalence of QTc prolongation and complex ventricular arrhythmias in patients with anti-Ro antibody (anti-Ro Ab)-positive autoimmune diseases. We tested the hypothesis that anti-Ro Abs target the HERG (human ether-a-go-go-related gene) K + channel, which conducts the rapidly activating delayed K + current, I Kr , thereby causing delayed repolarization seen as QT interval prolongation on the ECG. Methods and Results-Anti-Ro Ab-positive sera, purified IgG, and affinity-purified anti-52kDa Ro Abs from patients with autoimmune diseases and QTc prolongation were tested on I Kr using HEK293 cells expressing HERG channel and native cardiac myocytes. Electrophysiological and biochemical data demonstrate that anti-Ro Abs inhibit I Kr to prolong action potential duration by directly binding to the HERG channel protein. The 52-kDa Ro antigen-immunized guinea pigs showed QTc prolongation on ECG after developing high titers of anti-Ro Abs, which inhibited native I Kr and crossreacted with guinea pig ERG channel. Conclusions-The data establish that anti-Ro Abs from patients with autoimmune diseases inhibit I Kr by cross-reacting with the HERG channel likely at the pore region where homology between anti-52-kDa Ro antigen and HERG channel is present. The animal model of autoimmune-associated QTc prolongation is the first to provide strong evidence for a pathogenic role of anti-Ro Abs in the development of QTc prolongation. It is proposed that adult patients with anti-Ro Abs may benefit from routine ECG screening and that those with QTc prolongation should receive counseling about drugs that may increase the risk for life-threatening arrhythmias. (QTc prolongation) 7-10 but not with conduction abnormalities (complete atrioventricular block), which is well described in children born to mothers with anti-Ro Abs.
T he long-QT syndrome (LQTS) is one of the most studied channelopathies in which abnormal prolongation of ventricular repolarization predisposes to the life-threatening ventricular arrhythmia Torsades de Pointes. [1] [2] [3] [4] LQTS can be congenital or acquired. Although congenital LQTS is caused by mutations in ion channel protein-coding genes, acquired LQTS is often drug induced. 3, 5, 6 In most cases of drug-induced QT prolongation, the target ion channel is the HERG (Human Ether-à-go-go-Related Gene) encoding the pore-forming subunits (Kv11.1) of the rapidly activating delayed K + channel conducting I Kr .
1,3-5 I Kr plays a major role during repolarization frequent in the course of autoimmune diseases, particularly Sjӧgren syndrome, and systemic lupus erythematosus but also in other connective tissue diseases (CTDs) including mixed CTDs, undifferentiated CTDs, polymyositis ⁄dermatomyosi-tis, systemic sclerosis, rheumatoid arthritis, and even primary biliary cirrhosis. 11, 12 Interestingly, in the adult patients, anti-Ro Ab positivity is associated with repolarization abnormalities (QTc prolongation) [7] [8] [9] [10] but not with conduction abnormalities (complete atrioventricular block), which is well described in children born to mothers with anti-Ro Abs. 13, 14 Accordingly, it is assumed that the adult heart does not represent an immunological target for anti-Ro Abs. However, emerging clinical observations suggest that anti-Ro Abs may be arrhythmogenic for the adult heart by causing QT interval prolongation. [7] [8] [9] [10] Specifically, in a cohort of CTD patients, more than half (58%) of patients with anti-Ro Abs displayed a prolonged QTc, with a mean QTc duration significantly longer in anti-Ro Ab-positive versus anti-Ro Ab-negative patients. 7 In a subsequent study, patients with CTD and anti-Ro Ab showed 5-fold higher incidence of complex ventricular arrhythmias compared with anti-Ro Ab-negative patients. 9 Despite this high incidence of QTc prolongation and ventricular arrhythmias in patients with CTD, the pathogenesis of this autoimmuneassociated QTc prolongation in the adult remains poorly understood.
Methods

Study Population
Sera from 6 CTD patients were studied (see Table 1 ). Three CTD patients were anti-Ro Ab positive with QTc >460 milliseconds, and 3 CTD patients were anti-Ro Ab negative with QTc <460 milliseconds. 15 Patients did not have echocardiographic abnormalities or evidence of organic heart diseases, diabetes mellitus, renal failure, thyroid disease, or electrolyte abnormalities, 7, 9 and none were taking drugs that can potentially affect the QT interval. Genetic testing for mutations in the KCNH2, KCNQ1, SCN5A, KCNE2, KCNE1, and KCNJ2 genes was negative in the 3 anti-Ro Ab-positive patients studied. The Institutional Review Board approved the consent process for study participants, and patients gave informed consent. ECG recordings are described in the Methods section in the online-only Data Supplement.
Purification of IgG and Affinity Purification of Anti-52-kDa Ro Antibodies From Patients' Sera
IgG and affinity purification of anti-52-kDa Ro (52Ro) Abs was performed as previously described with modifications 16, 17 and as detailed in the Methods section in the online-only Data Supplement.
Electrophysiology With HEK293 Cells Stably Expressing HERG Channel and Guinea Pig Ventricular Myocytes
Details of DNA constructs and the methods of stable transfection of HEK293 cells with HERG channel were reported elsewhere. 18 The electrophysiology recording and single ventricular myocytes enzymatic dissociation technique are detailed in the Methods section in the online-only Data Supplement and elsewhere.
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Western Blot Analysis
Western blot experiments were performed as described in the Methods section in the online-only Data Supplement.
Guinea Pig Immunization
Seven adult guinea pigs (5 females and 2 males) were immunized with recombinant 52-kDa Ro antigen (Sigma), initially at day 1 and followed by boosters at days 14, 28, and 42 as described in the Methods section in the online-only Data Supplement and as previously reported with modification. 16, [20] [21] [22] 
ELISA Test
Serum from each immunized guinea pig was analyzed for anti-Ro Ab reactivity by ELISA as previously described 16, 20 with some modifications reported in the Methods section in the online-only Data Supplement.
Statistical Analysis
Statistical comparisons were evaluated with paired Student t tests and with nonparametric Wilcoxon paired tests as appropriate. Data are presented as mean±SEM. A value of P<0.05 was considered significant.
Results
Anti-Ro Ab-Positive Sera From Patients With QTc Prolongation Inhibit I Kr
We first tested the electrophysiological effect of whole serum containing anti-Ro Abs from a patient who has CTD and a long QTc of 566 milliseconds ( Figure 1A ). Figure 1B shows the voltage protocol used to record I Kr . Anti-Ro Ab-positive serum 1 (200 μL; 83 U/mL) inhibited both the peak and tail of I Kr recorded from HEK293 cells stably expressing the HERG channel ( Figure 1C-1F ). Selected current traces are shown before ( Figure 1C ) and after ( Figure 1D ) the application of anti-Ro Ab-positive serum. The I-V relationships for I Kr peak and tail before and after the application of anti-Ro Ab-positive serum are shown in Figure 1E (n=10) and Figure 1F (n=10), respectively. Anti-Ro Ab-positive serum significantly reduced I Kr peak density by 40.4% from 53.9±5.1 to 32.1±5.2 pA/pF at −10 mV (P<0.0001; n=10) and reduced I Kr tail density by 38.4% from 93.4±8.7 to 57.5±10.2 pA/pF at −10 mV (P<0.0001; n=10). To ensure reproducibility of I Kr inhibition, sera from 2 additional anti-Ro Ab-positive CTD patients with QTc of 514 and 498 milliseconds were tested (Table 1 ). The results show that serum 2 (200 μL; 241 U/mL) and serum 3 (200 μL; 241 U/mL) both significantly (P<0.0001; n=10 each) inhibited I Kr peak and tail densities ( Figure 1G ). Figure 2A ) had no effect on I Kr . Figure 2 shows selected I Kr traces before ( Figure 2B ) and after ( Figure 2D ) application of anti-Ro Ab-negative serum. Figure 2D and 2E shows I-V relationships of I Kr peak and tail densities before and after the application of anti-Ro Ab-negative serum (n=10), respectively. I Kr peak densities before and after the application of anti-Ro Ab-negative serum at −10 mV were 56.9±6.4 and 53.1±6.8 pA/pF (P=0.08; n=10), and I Kr tail densities were 94.5±9.2 and 89.2±7.3 pA/pF (P=0.09; n=10). Similarly, additional sera from 2 anti-Ro-negative CTD patients with QTc of 451 and 430 milliseconds (Table 1) had no significant effect on I Kr peak or tail current densities ( Figure 2F ).
Anti-Ro
Anti-Ro Ab-Positive Purified IgG From Patients With Long QTc Inhibits I Kr
The effect of purified IgG containing anti-Ro Abs from serum 1 was tested on I Kr . Figure 3 shows that purified IgG (75 μg/mL) significantly inhibited both I Kr peak and tail densities at several tested voltages. I Kr peak density at −10 mV decreased by 33.1% from 50.1±4.0 to 33.6±3.8 pA/pF (P<0.0001; n=10), and I Kr tail density decreased by 35.4% from 95.5±5.4 to 61.7±5.7 pA/pF (P<0.0001; n=10) on IgG application. The dose-dependent effect of IgG on I Kr is shown in Figure 4A . Anti-Ro Ab-positive IgG inhibited I Kr peak density in dose-dependent manner (n=6) with an EC 50 =87.3 μg/mL. Figure 4B shows a representative time course for I Kr peak inhibition by anti-Ro Ab-positive IgG (75 μg/mL). IgG inhibited I Kr peak in a time-dependent manner with a steady-state effect reached after 8 minutes after IgG application. The inhibition of I Kr by IgG was only partially reversible (washout). Figure 4C shows that antiRo Ab-negative IgG at −10 mV did not significantly inhibit I Kr peak densities (from 49.4±7.1 to 46.3±5.2 pA/pF; n=6; P=0.1) or I Kr tail densities (from 92.2±7.4 to 88.3±8.1 pA/ pF; n=6; P=0.09). Figure 4D illustrates the time course of I Kr peak without any intervention and shows minimal run-down seen in 6 experiments. To investigate whether the above IgG containing anti-Ro Ab inhibition of I Kr occurs by affecting the kinetics of the HERG channel, the activation and deactivation time constants (τ) were fitted by the Boltzmann equation. Figure 4E and 4F demonstrates that both activation and 
Anti-Ro Ab-Positive IgG but Not Anti-Ro AbNegative IgG Cross-Reacts With HERG Channels
To test whether the inhibition of I Kr by anti-Ro Ab-positive IgG is due to a direct interaction with the HERG channel protein, Western blot experiments were performed with proteins from HEK293 cells stably expressing HERG channels (n=6) and untransfected HEK293 cells (negative control, n=6). Figure 5A shows that anti-Ro Abpositive IgG did not recognize any bands in untransfected HEK293 cells (lane 1) but recognized 2 bands at ≈155 and 135 kDa (lane 2), corresponding to the glycosylated and endoplasmic reticulum-retained HERG channel, consistent with previous reports. 18, 23 Figure 5B 
Affinity Purified Anti-52Ro Abs From a Patient With Long QTc Inhibits I Kr
To demonstrate the specificity the effect of anti-Ro Abs on I Kr , affinity-purified anti-52Ro Abs from sera 1 were tested on I Kr . Similar to purified IgG, affinity-purified anti-52Ro Abs (52 μg/mL) significantly inhibited I Kr peak densities by 28.5% (from 35.4±2.6 to 25.3±2.4 pA/pF; n=10; P<0.0001) and I Kr tail densities by 30.5% (from 62.7±5.9 to 43.5±4.7; n=10; P<0.0001). Figure 6 shows current tracings ( Figure 6A and 6B), I-V relationships ( Figure 6C and 6D) , and dot plot ( Figure 6E ) before and after the application of affinity-purified anti-52Ro Abs.
Immunization of Adult Guinea Pigs With SSA/52kDa Ro Antigen Causes QTc Prolongation
To further demonstrate the potential role of anti-Ro Abs in the pathogenesis of QTc prolongation, we sought to establish an animal model of anti-Ro Ab-induced QTc Figure 2 . Anti-Ro antibody (Ab)-negative serum has no effect on I Kr . A, Twelve-lead ECG of control patient 4 who is anti-Ro Ab negative and has a normal QTc of 404 milliseconds. Vertical lines in lead II show the QT interval. Currents were recorded from HEK293 stably expressing HERG channels using the protocol shown in Figure 1B . B, I Kr current traces during basal conditions and (C) in the presence of anti-Ro Ab-negative serum (200 μL). I-V relationships during basal conditions (circles) and anti-Ro Ab-negative serum (triangles) for I Kr peak (D) and tail (E). F, Summary dot plot of I Kr peak and tail densities in the presence of anti-Ro Ab-negative sera from 3 different patients with normal QTc (<460 milliseconds) and connective tissue disease.
by guest on April 20, 2017 http://circ.ahajournals.org/ Downloaded from July 28, 2015 prolongation. The guinea pig is a suitable animal model for QT studies because of the similarities of ECG features with humans. 24, 25 The results in Table 2 show significant QTc prolongation and high titers of anti-Ro Abs after immunization in 7 guinea pigs. No significant differences in heart rate, PR intervals, and QRS durations were observed before and after immunization. Figure 7 illustrates ECGs from a guinea pig before ( Figure 7A ) and after ( Figure 7B ) immunization with a ΔQTc of 36 milliseconds. If the QTc prolongation seen in the immunized guinea pigs is due, at least in part, to the inhibition of I Kr by anti-Ro Ab, then anti-Ro Abs should be expected to also lengthen the ventricular AP duration (APD). Thus, APs were recorded from guinea pig single ventricular myocytes before and after the application of anti-Ro-positive IgG at 0.5 Hz in the current clamp mode configuration. Figure 7C shows APs before (left) and after (right) the application of anti-Ro Ab-positive IgG (75 μg/mL). Anti-Ro Ab-positive IgG resulted in a prolongation of the APD at 90% (APD 90 ) by 39.7% without any changes in the resting membrane potential or the AP amplitude. Averaged data from a total of 6 experiments are shown in Figure 7C (bottom). Anti-Ro Ab-negative IgG did not have any significant effects on APD 90 (348.4±32.1 milliseconds before and 350.2±39.3 milliseconds after negative IgG; P=0.1; n=6). Figure 7D shows I Kr recorded from guinea pig ventricular myocytes using a short-duration (200 milliseconds) pulse protocol from a holding potential of −40 mV in which the slow delayed rectifier, I Ks , is still inactive (and in the presence of 10 μmol/L chromanol). Consistent with the observed APD lengthening, anti-Ro Ab-positive IgG (75 μg/mL), but not control anti-Ro Ab-negative IgG (75 μg/mL), 
Homology Analysis and Reactivity of Sera to the Peptide Corresponding to HERG Extracellular Loop at the Pore Region
Linear homology analysis showed that there is 44% homology between 52Ro protein (aa302-aa321) and HERG α 1 subunit (aa574-aa598) at the pore region ( Figure 8C-a-8C-c) , of which 25% are identical. The presence of this homology at the pore region may account for anti-Ro Ab off-target binding to HERG channel at this epitope mimic, especially in the tetrameric conformation model of the channel where the 4 pore extracellular loops come together and are accessible to the antibodies (Figure 8C-c) . 26 This was tested by performing ELISA with patients' sera and a synthesized 31-amino acid peptide corresponding to the pore-forming region of the HERG channel (Figure 8C-a) . Figure 8C -d shows that antiRo Ab-positive sera (n=3) but not anti-Ro Ab-negative sera (n=3) exhibited high reactivity with the peptide. The average 
Discussion
Here, we describe the pathogenesis underlying a novel form of acquired QT prolongation of autoimmune origin associated with anti-Ro Abs in adults. The in vitro data show that serum and purified IgG containing anti-Ro Abs and affinitypurified anti-52Ro Abs from CTD patients with QTc prolongation functionally inhibit I Kr in a time-and dose-dependent manner by direct interaction with the HERG/Kv11. 
Autoimmune-Associated Electric Abnormalities in Clinical Settings
The most well-characterized autoimmune disease in which anti-Ro Abs are associated with electrical abnormalities is congenital heart block detected at or before birth in a structurally normal heart. 14, 27 The hallmark of congenital heart block is the irreversible complete atrioventricular block that affects exclusively the fetus or the newborn heart but curiously not the adult maternal heart despite exposure to the identical circulating anti-Ro Abs. 14, 27 QTc prolongation has also been reported in newborns 28, 29 of mothers with anti-Ro Abs but resolves over time with the disappearance of Abs, 30 close ECG monitoring of anti-Ro Ab-positive neonates was proposed. 31 Recently, clinical evidence has demonstrated a correlation between the presence of anti-Ro Abs and QTc prolongation in adult patients with autoimmune diseases. 7, 9, 10, 32 Our experimental findings support and are consistent with these clinical observations from different groups that the presence of anti-Ro Abs correlates with QTc prolongation. [7] [8] [9] [10] 32 A study by Bourré-Tessier et al 10 analyzing a large cohort of 278 patients affected with systemic lupus erythematosus found that the occurrence of QTc prolongation was ≈8-fold more likely in anti-Ro Ab-positive than-negative patients. Similarly, Lazzerini et al 7, 9 found that about half of anti-Ro/SSA-positive patients displayed a prolonged QTc and increased propensity for ventricular arrhythmias. 9 However, other studies did not show any significant differences in mean QTc, likely because of the type of autoimmune disease studied, the age of the patients, the titers of Abs, and the methods used for analysis of Abs.
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Animal Model of Autoimmune-Associated QTc Prolongation
To correlate the arrhythmogenic effects of anti-Ro Abs with the genesis of QT interval prolongation, guinea pigs were immunized with 52Ro antigen to generate anti-52Ro Abs. The data from this in vivo study are the first to establish an animal model of autoimmune-associated QTc prolongation and to provide evidence for a pathogenic role of anti-52Ro Abs in the development of QTc prolongation. Moreover, anti52Ro Ab-positive but not -negative sera from immunized . Affinity-purified anti-52-kDa Ro antibody (Ab) inhibits I Kr . Currents were recorded from HEK293 stably expressing HERG channels using the protocol shown in Figure 1B . A, Representative current traces under basal conditions and (B) in the presence of 52 μg/mL affinity-purified anti-52-kDa Ro Ab from sera 1. I-V relationships of I Kr peak (C) and tail (D) densities during basal (circles) and affinity-purified anti-Ro Abs application (triangles). The corresponding dot plot at −10 mV is shown in E for I Kr peak and tail densities before and after IgG. *Statistical significance at P<0.05 (n=10). 
Pathogenesis of Autoimmune-Associated QTc Prolongation
The proposed mechanism for the autoimmune-associated QTc prolongation is that anti-Ro Abs cause APD and QTc prolongations by direct block of the HERG/Kv11.1 channels. Several lines of evidence support this proposed mechanism:
(1) Only sera, IgG, and affinity-purified anti-Ro Abs from anti-Ro Ab-positive patients, not from anti-Ro-negative patients, inhibited I Kr and directly interacted with HERG/ Kv11.1 channel proteins both in expression systems and in native ventricular myocytes; (2) anti-Ro Abs did not affect I Kr kinetics, and their effect was observed within minutes, suggesting a direct block of the HERG channel; (3) the homology between the 52Ro antigen and HERG channel at the poreforming region may account for anti-Ro Abs targeting and blocking the pore of the HERG channel (This is supported by the tetrameric 3-dimensional model of the HERG pore region showing the accessibility of the extracellular loop between S5 and S6 to antibodies; Figure 8C -c); (4) the reactivity of anti-Ro Ab-positive but not anti-Ro Ab-negative sera to the peptide corresponds to the pore-forming region of HERG; (5) the sole presence of anti-Ro Abs induced by immunization of guinea pigs resulted in QTc prolongation on the surface ECG; and (6) anti-Ro Abs do not affect other currents such as the delayed rectifier K current, I Ks ; the transient outward current, I to ; the inward rectifier K current, I K1 ; and the Na current, I Na . 36, 37 Because it is generally accepted that the QT interval is a function of ventricular APD and that the 2 variables are very closely correlated in humans 38, 39 and animals, 40 the combined in vitro and in vivo data from this study provided important clues to the relationship among ion channel block, APD lengthening, and QT interval prolongation. Abnormal QTc interval prolongation is known to predispose to ventricular arrhythmias known as Torsades de Pointes via early afterdepolarization-induced triggered activity. Thus, anti-Ro Ab-induced QTc prolongation confers an increased risk of ventricular arrhythmias not only for patients with anti-Ro Abs but also for patients with genetic or drug-induced QTc prolongation. In fact, anti-Ro Ab is the most frequent autoantibody found in the general population (up to ≈3%), but anti-Ro Ab-positive patients are in most cases asymptomatic for autoimmune diseases. 41 The involvement of anti-Ro Abs and the HERG channel in the pathogenesis of QTc prolongation is further supported by a case report in which I Kr has been shown to be inhibited by anti-Ro Abs from a female patient (asymptomatic for autoimmune diseases) with acquired LQTS with no known cause of QTc prolongation except positive anti-Ro Abs. 42 Both clinical and experimental evidence supports the association of anti-Ro Abs with QTc prolongation in adult patients and pinpoints the inhibition of the HERG/ Kv11.1 channel by anti-Ro Abs as a plausible underlying mechanism.
Significance
Patients with QTc prolongation are prone to complex ventricular arrhythmias, including Torsades de Pointes, syncope, and sudden death. 3, 4 QTc prolongation associated with anti-Ro Abs per se may confer an increased risk for developing ventricular arrhythmias and represents an additional risk factor for patients with drug-induced or congenital QTc prolongation. The finding from the present study supports the recommendations that adult patients with anti-Ro Abs may benefit from routine ECG screening for QTc prolongation and that those already identified with anti-Ro Ab-associated QTc prolongation should receive counseling, including education about avoiding drugs and other conditions known to prolong the QT interval. 
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Supplemental Methods
ECG recordings in patients:
In this study, QTc was considered prolonged if ≥460 ms in accordance with the AHA/ACC/HRS recommendations 1 . QT interval was manually measured on a 12-lead ECG from the onset of the Q wave or the onset of the QRS complex to the end of the T wave, defined as the return to the T-P baseline. When U waves are present, the QT interval was measured to the nadir of the curve between the T and U waves. QT interval, determined as the longest measured QT interval in any lead, was corrected for heart rate by Bazett's formula (dividing the QT interval by the square root of the R-R interval) to yield the QTc value. QTc is measured by a single investigator who was blinded to the patient's Abs status.
Purification of IgG and affinity purification of anti-52kDa/Ro antibodies from patients' sera: IgG purification was performed using Melon Gel IgG spin purification Kit (Thermo scientific). Briefly, 10-100 μL of serum per 100 μL of settled gel was used and the Melon Gel
IgG purification support and purification buffer was equilibrated to room temperature. To obtain an even suspension, bottle containing the purification support was swirled and a 500 μL of slurry and dispensed into a spin column placed in a micro centrifuge tube. The uncapped column/tube assembly was centrifuged at 2,000-6,000 ×g for 1 minute. Purification buffer (300 μL) was added to the column, pulse centrifuged for 10 seconds and flow through discarded. 100-500 μL of diluted or 10-100 μL of buffer-exchanged serum was added to the column and incubated for 5 minutes at room temperature with end-over-end mixing. Centrifugation for 1 minute was performed to collect the purified Ab. For affinity purification of anti-52kDa Ro (52Ro) Abs, 
Guinea-pig ventricular myocytes:
All experiments were performed in accordance with the IACUC at the VA New York Harbor Healthcare System and conform to the NIH guidelines.
Guinea pigs were anesthetized with isoflurane and the heart was rapidly excised and Langendorff perfused with the following Tyrode's solution (in mM): 140 NaCl, 4.5 KCl, 2 CaCl2, 10 dextrose, 1 MgCl2, and 10 HEPES (pH = 7.4) for 2 min. The heart was then perfused with a Cafree Tyrode's solution followed by collagenase B (final concentration, 1mg/ml; Boehringer Mannheim, Indianapolis, IN). The dispersed cells were resuspended in KB solution and
IgG antibody (Jackson Immunolab) at a 1:5000 and 1:10,000 dilution. The signal was detected with Clarity ECL substrate (Bio-Rad) and blots were scanned in a C-Digit blot scanner (LI-COR)
at high sensitivity to obtain the image. Because HERG channel delineates Human K channel, we used Kv11.1 to indicate the ERG K channel from guinea-pigs.
Guinea-pigs immunization:
Antibody levels were checked at days 14, 28 and 42 by ELISA as described below. The ECG was recorded from slightly anesthetized (2-4% isoflurane) guineapigs in lead II and analyzed using a digital acquisition and analysis system (Power Lab/4SP).
QTc was calculated using Bazett's formula as it is more suitable for anesthetized guinea-pigs 3 . ELISA using patients' sera and the peptide was performed as above except for the use of goat anti-Human IgG.
ELISA:
